CONMED Corporation (CNMD)
USD 69.32
(-2.68%)
USD 69.32
(-2.68%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 64.45 Million USD | 179.99% |
| 2022 | -80.58 Million USD | -228.84% |
| 2021 | 62.54 Million USD | 557.16% |
| 2020 | 9.51 Million USD | -66.75% |
| 2019 | 28.62 Million USD | -29.95% |
| 2018 | 40.85 Million USD | -26.37% |
| 2017 | 55.48 Million USD | 278.39% |
| 2016 | 14.66 Million USD | -51.92% |
| 2015 | 30.49 Million USD | -5.26% |
| 2014 | 32.19 Million USD | -10.43% |
| 2013 | 35.93 Million USD | -11.22% |
| 2012 | 40.48 Million USD | 5283.11% |
| 2011 | 752 Thousand USD | -97.52% |
| 2010 | 30.34 Million USD | 150.03% |
| 2009 | 12.13 Million USD | -72.76% |
| 2008 | 44.56 Million USD | 7.49% |
| 2007 | 41.45 Million USD | 431.46% |
| 2006 | -12.5 Million USD | -139.09% |
| 2005 | 31.99 Million USD | -4.4% |
| 2004 | 33.46 Million USD | 4.31% |
| 2003 | 32.08 Million USD | -6.06% |
| 2002 | 34.15 Million USD | 39.93% |
| 2001 | 24.4 Million USD | 26.36% |
| 2000 | 19.31 Million USD | -28.99% |
| 1999 | 27.2 Million USD | 52.81% |
| 1998 | 17.8 Million USD | 350.7% |
| 1997 | -7.1 Million USD | -143.56% |
| 1996 | 16.3 Million USD | 49.54% |
| 1995 | 10.9 Million USD | 101.85% |
| 1994 | 5.4 Million USD | 485.71% |
| 1993 | -1.4 Million USD | -134.15% |
| 1992 | 4.1 Million USD | 5.13% |
| 1991 | 3.9 Million USD | 62.5% |
| 1990 | 2.4 Million USD | 900.0% |
| 1989 | -300 Thousand USD | -137.5% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 19.7 Million USD | -40.4% |
| 2024 Q3 | 48.98 Million USD | 63.41% |
| 2024 Q2 | 29.97 Million USD | 52.09% |
| 2023 Q3 | 15.83 Million USD | 15.33% |
| 2023 Q4 | 33.07 Million USD | 108.82% |
| 2023 FY | 64.45 Million USD | 179.99% |
| 2023 Q2 | 13.73 Million USD | 654.92% |
| 2023 Q1 | 1.81 Million USD | -93.16% |
| 2022 Q3 | 46.15 Million USD | 127.42% |
| 2022 Q4 | 26.58 Million USD | -42.4% |
| 2022 Q1 | 14.97 Million USD | -38.74% |
| 2022 FY | -80.58 Million USD | -228.84% |
| 2022 Q2 | -168.29 Million USD | -1223.81% |
| 2021 Q2 | 13.29 Million USD | 34.79% |
| 2021 Q1 | 9.86 Million USD | -59.15% |
| 2021 Q3 | 14.94 Million USD | 12.48% |
| 2021 Q4 | 24.44 Million USD | 63.53% |
| 2021 FY | 62.54 Million USD | 557.16% |
| 2020 Q4 | 24.14 Million USD | 252.41% |
| 2020 Q3 | 6.85 Million USD | 125.0% |
| 2020 Q2 | -27.4 Million USD | -562.29% |
| 2020 Q1 | 5.92 Million USD | -60.31% |
| 2020 FY | 9.51 Million USD | -66.75% |
| 2019 Q1 | 1.02 Million USD | -93.48% |
| 2019 FY | 28.62 Million USD | -29.95% |
| 2019 Q2 | 5.69 Million USD | 457.79% |
| 2019 Q3 | 6.97 Million USD | 22.39% |
| 2019 Q4 | 14.93 Million USD | 114.25% |
| 2018 FY | 40.85 Million USD | -26.37% |
| 2018 Q2 | 8.71 Million USD | -18.19% |
| 2018 Q1 | 10.65 Million USD | -77.18% |
| 2018 Q4 | 15.65 Million USD | 168.72% |
| 2018 Q3 | 5.82 Million USD | -33.19% |
| 2017 Q3 | 7.19 Million USD | 17.23% |
| 2017 Q1 | -4.54 Million USD | -167.75% |
| 2017 FY | 55.48 Million USD | 278.39% |
| 2017 Q4 | 46.69 Million USD | 548.83% |
| 2017 Q2 | 6.13 Million USD | 235.07% |
| 2016 FY | 14.66 Million USD | -51.92% |
| 2016 Q4 | 6.7 Million USD | -8.57% |
| 2016 Q1 | -2.26 Million USD | -128.85% |
| 2016 Q3 | 7.33 Million USD | 154.4% |
| 2016 Q2 | 2.88 Million USD | 227.33% |
| 2015 FY | 30.49 Million USD | -5.26% |
| 2015 Q3 | 8.87 Million USD | 18.93% |
| 2015 Q4 | 7.85 Million USD | -11.51% |
| 2015 Q2 | 7.46 Million USD | 18.2% |
| 2015 Q1 | 6.31 Million USD | -44.33% |
| 2014 Q1 | 8.62 Million USD | -15.65% |
| 2014 FY | 32.19 Million USD | -10.43% |
| 2014 Q3 | 1.97 Million USD | -80.77% |
| 2014 Q2 | 10.25 Million USD | 18.88% |
| 2014 Q4 | 11.33 Million USD | 475.0% |
| 2013 Q1 | 10.49 Million USD | -3.72% |
| 2013 FY | 35.93 Million USD | -11.22% |
| 2013 Q4 | 10.22 Million USD | 79.83% |
| 2013 Q3 | 5.68 Million USD | -40.34% |
| 2013 Q2 | 9.53 Million USD | -9.14% |
| 2012 FY | 40.48 Million USD | 5283.11% |
| 2012 Q3 | 9.32 Million USD | -9.48% |
| 2012 Q2 | 10.29 Million USD | 3.29% |
| 2012 Q1 | 9.96 Million USD | 139.66% |
| 2012 Q4 | 10.89 Million USD | 16.92% |
| 2011 Q4 | -25.13 Million USD | -406.1% |
| 2011 FY | 752 Thousand USD | -97.52% |
| 2011 Q2 | 8.68 Million USD | -3.5% |
| 2011 Q3 | 8.21 Million USD | -5.4% |
| 2011 Q1 | 8.99 Million USD | 29.18% |
| 2010 Q2 | 7.3 Million USD | -0.18% |
| 2010 Q3 | 8.75 Million USD | 19.87% |
| 2010 Q4 | 6.96 Million USD | -20.5% |
| 2010 FY | 30.34 Million USD | 150.03% |
| 2010 Q1 | 7.31 Million USD | 47.71% |
| 2009 Q2 | 1.4 Million USD | -68.58% |
| 2009 FY | 12.13 Million USD | -72.76% |
| 2009 Q4 | 4.95 Million USD | 284.7% |
| 2009 Q3 | 1.28 Million USD | -8.59% |
| 2009 Q1 | 4.48 Million USD | -57.6% |
| 2008 Q4 | 10.57 Million USD | 0.55% |
| 2008 Q3 | 10.51 Million USD | -15.54% |
| 2008 Q2 | 12.45 Million USD | 13.12% |
| 2008 Q1 | 11.01 Million USD | -6.96% |
| 2008 FY | 44.56 Million USD | 7.49% |
| 2007 Q3 | 8.35 Million USD | -10.59% |
| 2007 Q2 | 9.34 Million USD | -21.62% |
| 2007 FY | 41.45 Million USD | 431.46% |
| 2007 Q4 | 11.83 Million USD | 41.64% |
| 2007 Q1 | 11.92 Million USD | 150.53% |
| 2006 Q4 | -23.59 Million USD | -808.07% |
| 2006 FY | -12.5 Million USD | -139.09% |
| 2006 Q3 | 3.33 Million USD | -2.4% |
| 2006 Q2 | 3.41 Million USD | -21.34% |
| 2006 Q1 | 4.34 Million USD | 54.61% |
| 2005 FY | 31.99 Million USD | -4.4% |
| 2005 Q4 | 2.8 Million USD | -64.53% |
| 2005 Q3 | 7.91 Million USD | -24.69% |
| 2005 Q2 | 10.5 Million USD | -2.39% |
| 2005 Q1 | 10.76 Million USD | 44.79% |
| 2004 Q1 | 12.03 Million USD | -7.0% |
| 2004 Q4 | 7.43 Million USD | 337.61% |
| 2004 Q2 | 12.29 Million USD | 2.1% |
| 2004 Q3 | 1.69 Million USD | -86.18% |
| 2004 FY | 33.46 Million USD | 4.31% |
| 2003 Q2 | 2.76 Million USD | -81.03% |
| 2003 Q4 | 12.94 Million USD | 33.37% |
| 2003 Q1 | 14.56 Million USD | 84.36% |
| 2003 FY | 32.08 Million USD | -6.06% |
| 2003 Q3 | 9.7 Million USD | 251.28% |
| 2002 FY | 34.15 Million USD | 39.93% |
| 2002 Q1 | 9.07 Million USD | 18.58% |
| 2002 Q2 | 8.95 Million USD | -1.39% |
| 2002 Q3 | 8.22 Million USD | -8.12% |
| 2002 Q4 | 7.9 Million USD | -3.9% |
| 2001 Q1 | 6 Million USD | 6.06% |
| 2001 FY | 24.4 Million USD | 26.36% |
| 2001 Q4 | 7.65 Million USD | 52.62% |
| 2001 Q3 | 5.01 Million USD | -12.54% |
| 2001 Q2 | 5.73 Million USD | -4.48% |
| 2000 FY | 19.31 Million USD | -28.99% |
| 2000 Q1 | 7.4 Million USD | -13.85% |
| 2000 Q2 | 3.51 Million USD | -52.54% |
| 2000 Q3 | 2.72 Million USD | -22.38% |
| 2000 Q4 | 5.66 Million USD | 107.4% |
| 1999 Q1 | 6.3 Million USD | -3.08% |
| 1999 Q2 | 6.7 Million USD | 6.35% |
| 1999 Q4 | 8.6 Million USD | 53.57% |
| 1999 Q3 | 5.6 Million USD | -16.42% |
| 1999 FY | 27.2 Million USD | 52.81% |
| 1998 Q3 | 5.9 Million USD | 31.11% |
| 1998 FY | 17.8 Million USD | 350.7% |
| 1998 Q2 | 4.5 Million USD | 400.0% |
| 1998 Q4 | 6.5 Million USD | 10.17% |
| 1998 Q1 | 900 Thousand USD | 105.11% |
| 1997 Q1 | 2.5 Million USD | -47.92% |
| 1997 Q3 | 4.5 Million USD | 28.57% |
| 1997 Q2 | 3.5 Million USD | 40.0% |
| 1997 Q4 | -17.6 Million USD | -491.11% |
| 1997 FY | -7.1 Million USD | -143.56% |
| 1996 Q3 | 4 Million USD | -4.76% |
| 1996 Q1 | 3.3 Million USD | -2.94% |
| 1996 Q4 | 4.8 Million USD | 20.0% |
| 1996 FY | 16.3 Million USD | 49.54% |
| 1996 Q2 | 4.2 Million USD | 27.27% |
| 1995 Q1 | 1.8 Million USD | 12.5% |
| 1995 Q4 | 3.4 Million USD | 17.24% |
| 1995 Q3 | 2.9 Million USD | 3.57% |
| 1995 FY | 10.9 Million USD | 101.85% |
| 1995 Q2 | 2.8 Million USD | 55.56% |
| 1994 Q1 | 1.1 Million USD | 145.83% |
| 1994 FY | 5.4 Million USD | 485.71% |
| 1994 Q4 | 1.6 Million USD | 14.29% |
| 1994 Q3 | 1.4 Million USD | 7.69% |
| 1994 Q2 | 1.3 Million USD | 18.18% |
| 1993 Q3 | 400 Thousand USD | 100.0% |
| 1993 Q4 | -2.4 Million USD | -700.0% |
| 1993 FY | -1.4 Million USD | -134.15% |
| 1993 Q1 | 500 Thousand USD | -44.44% |
| 1993 Q2 | 200 Thousand USD | -60.0% |
| 1992 Q2 | 1.2 Million USD | -7.69% |
| 1992 Q1 | 1.3 Million USD | 8.33% |
| 1992 FY | 4.1 Million USD | 5.13% |
| 1992 Q3 | 700 Thousand USD | -41.67% |
| 1992 Q4 | 900 Thousand USD | 28.57% |
| 1991 FY | 3.9 Million USD | 62.5% |
| 1991 Q1 | 800 Thousand USD | 33.33% |
| 1991 Q4 | 1.2 Million USD | 9.09% |
| 1991 Q3 | 1.1 Million USD | 22.22% |
| 1991 Q2 | 900 Thousand USD | 12.5% |
| 1990 Q2 | 600 Thousand USD | 0.0% |
| 1990 FY | 2.4 Million USD | 900.0% |
| 1990 Q4 | 600 Thousand USD | 0.0% |
| 1990 Q3 | 600 Thousand USD | 0.0% |
| 1990 Q1 | 600 Thousand USD | 220.0% |
| 1989 Q2 | - USD | 0.0% |
| 1989 Q4 | -500 Thousand USD | -150.0% |
| 1989 FY | -300 Thousand USD | -137.5% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q3 | -200 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Abbott Laboratories | 5.72 Billion USD | 98.874% |
| Allurion Technologies Inc. | -82.3 Million USD | 178.318% |
| Artivion, Inc. | -30.69 Million USD | 310.033% |
| Avanos Medical, Inc. | -61.8 Million USD | 204.303% |
| Butterfly Network, Inc. | -133.69 Million USD | 148.212% |
| Butterfly Network, Inc. | -133.69 Million USD | 148.212% |
| Bio-Rad Laboratories, Inc. | -637.32 Million USD | 110.114% |
| Boston Scientific Corporation | 1.59 Billion USD | 95.954% |
| Perspective Therapeutics, Inc. | -14.67 Million USD | 539.393% |
| Edwards Lifesciences Corporation | 1.4 Billion USD | 95.404% |
| Paragon 28, Inc. | -47.84 Million USD | 234.736% |
| Glaukos Corporation | -134.66 Million USD | 147.868% |
| Globus Medical, Inc. | 122.87 Million USD | 47.54% |
| Inspire Medical Systems, Inc. | -21.15 Million USD | 404.727% |
| Integer Holdings Corporation | 90.65 Million USD | 28.892% |
| Medtronic plc | 3.67 Billion USD | 98.246% |
| Nevro Corp. | -92.21 Million USD | 169.902% |
| Owlet, Inc. | -32.9 Million USD | 295.918% |
| Penumbra, Inc. | 90.95 Million USD | 29.13% |
| Vicarious Surgical Inc. | -71.07 Million USD | 190.697% |
| Smith & Nephew plc | 263 Million USD | 75.491% |
| Sonendo, Inc. | -60.91 Million USD | 205.811% |
| STERIS plc | 378.23 Million USD | 82.958% |
| Stryker Corporation | 3.16 Billion USD | 97.963% |
| Vapotherm, Inc. | -58.19 Million USD | 210.768% |
| Zimmer Biomet Holdings, Inc. | 1.02 Billion USD | 93.705% |